Somewhat different

Onyx Pharmaceuticals Inc. said a lung-cancer clinical trial of its flagship drug Nexavar was halted because it wouldn’t meet its goal of prolonging patient survival. An article about Onyx and the Abreast of the Market column yesterday incorrectly said the study was halted because of increased death in patients taking the drug. Link

This entry was written by Craig Silverman, posted on February 22, 2008 at 8:00 am, filed under Newspapers and tagged . Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.
del.icio.us:Somewhat different digg:Somewhat different newsvine:Somewhat different furl:Somewhat different reddit:Somewhat different fark:Somewhat different Y!:Somewhat different smarking:Somewhat different

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*